Long-term exposure to telmisartan as monotherapy or combination therapy: Efficacy and safety

Blood Pressure

Volumn 11, Issue 3, 2002, Pages 173-181

  Freytag, Frank ^a   Holwerda, Nicolaas J ^a   Karlberg, Bengt E ^a   Meinicke, Thomas W ^a   Schumacher, Helmut ^a  

^a Kreiskrankenhaus Gunzenhausen ^*  (Germany)

Author keywords

Combination treatment; Efficacy; Hydrochlorothiazide; Long term safety; Monotherapy; Primary hypertension controlled trial; Telmisartan

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; PLACEBO; TELMISARTAN;

ADULT; AGED; ANGINA PECTORIS; ARTHRALGIA; ARTICLE; BACKACHE; BLOOD PRESSURE REGULATION; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ECZEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTENSION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; SYSTOLIC BLOOD PRESSURE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; CONSUMER PRODUCT SAFETY; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; THERAPEUTIC EQUIVALENCY;

EID: 0036300934     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370502760050412     Document Type: Article

References (30)

1. Organ protection and optimal blood pressure control
2. The benefits of lowering elevated blood pressure: A critical review of studies of cardiovascular morbidity and mortality in hypertension
3. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
4. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
5. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991
6. Blood pressure screening, management and control in England: Results from the health survey for England 1994
7. Low-dose antihypertensive combination therapy: Its rationale and role in cardiovascular risk management
8. Some problems with antihypertensive drug studies in the context of the new guidelines
9. The effect of prescribed daily dose frequency on patient medication compliance
10. Physiologic and hemodynamic considerations in blood pressure control while maintaining organ perfusion
11. Impact of age, race, and obesity on hypertensive mechanisms and therapy
12. The rationale for combination versus single-entity therapy in hypertension
13. Combination therapy with diuretics: An evolution of understanding
14. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology
15. Angiotensin II-receptor antagonists: An overview
16. 1 receptor antagonist telmisartan in patients with mild to moderate hypertension Adv. Ther
17. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension
18. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension
19. The incidence of cough: A comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist
20. A comparison of the efficacies and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine
21. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy
22. Comparison of a fixed-dose combination of telmisartan 40 mg plus hydrochlorothiazide 12.5 mg with telmisartan 40 mg in the control of mild-to-moderate hypertension
23. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension
24. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group trial
25. A comparison between the 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide, as required, in the treatment of hypertension
26. The efficacy and safety of telmisartan compared to atenolol and placebo in patients with hypertension
27. Safety and Efficacy of Long-term Exposure to monotherapy or Combination therapy with Telmisartan (SELECT)
28. 1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension
29. Telmisartan versus losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension - A randomized ABPM study
30. Once-daily telmisartan compared with enalapril in the treatment of hypertension